tradingkey.logo

National Research Corp

NRC
15.940USD
+0.010+0.06%
Close 02/06, 16:00ETQuotes delayed by 15 min
360.84MMarket Cap
30.76P/E TTM

National Research Corp

15.940
+0.010+0.06%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of National Research Corp

Currency: USD Updated: 2026-02-06

Key Insights

National Research Corp's fundamentals are relatively stable, with industry-average ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 112 out of 156 in the Professional & Commercial Services industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend up.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

National Research Corp's Score

Industry at a Glance

Industry Ranking
112 / 156
Overall Ranking
390 / 4521
Industry
Professional & Commercial Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

National Research Corp Highlights

StrengthsRisks
National Research Corporation, doing business as NRC Health, is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Its digital solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience, which can be implemented both collectively as an enterprise solution or individually to meet specific needs within the organization. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools. Its Reputation solutions allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs better consumer decision-making.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 45.67%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 45.67%.
Fairly Valued
The company’s latest PE is 30.76, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 11.09M shares, decreasing 18.65% quarter-over-quarter.
Held by Barrow Hanley
Star Investor Barrow Hanley holds 42.00 shares of this stock.

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of National Research Corp is 7.58, ranking 61 out of 156 in the Professional & Commercial Services industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 35.19M, representing a year-over-year decrease of 4.64%, while its net profit experienced a year-over-year decrease of 72.61%.

Score

Industry at a Glance

Previous score
7.58
Change
0

Financials

4.66

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

9.31

Operational Efficiency

8.98

Growth Potential

6.26

Shareholder Returns

8.70

National Research Corp's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of National Research Corp is 6.14, ranking 109 out of 156 in the Professional & Commercial Services industry. Its current P/E ratio is 30.76, which is 28.95% below the recent high of 39.66 and 68.06% above the recent low of 9.83.

Score

Industry at a Glance

Previous score
6.14
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 112/156
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

No earnings forecast score is currently available for National Research Corp. The Professional & Commercial Services industry's average is 7.68.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.
No Data

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of National Research Corp is 6.79, ranking 93 out of 156 in the Professional & Commercial Services industry. Currently, the stock price is trading between the resistance level at 20.84 and the support level at 12.99, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.81
Change
-0.02

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-1.513
Neutral
RSI(14)
35.295
Neutral
STOCH(KDJ)(9,3,3)
15.199
Oversold
ATR(14)
1.511
High Vlolatility
CCI(14)
-137.525
Sell
Williams %R
87.203
Oversold
TRIX(12,20)
-0.142
Sell
StochRSI(14)
11.636
Oversold
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
17.332
Sell
MA10
18.801
Sell
MA20
20.043
Sell
MA50
18.754
Sell
MA100
16.212
Sell
MA200
15.437
Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of National Research Corp is 3.00, ranking 111 out of 156 in the Professional & Commercial Services industry. The latest institutional shareholding proportion is 49.01%, representing a quarter-over-quarter decrease of 5.05%. The largest institutional shareholder is The Vanguard, holding a total of 831.38K shares, representing 3.67% of shares outstanding, with 10.31% decrease in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Amandla MK Trust
4.76M
--
Common Property Trust LLC
3.85M
--
Kayne Anderson Rudnick Investment Management, LLC
2.75M
-7.91%
Hays (Michael D)
1.39M
+1326.95%
BlackRock Institutional Trust Company, N.A.
857.06K
-0.59%
The Vanguard Group, Inc.
Star Investors
921.40K
+0.20%
Atlanta Capital Management Company, L.L.C.
674.77K
-4.26%
Dimensional Fund Advisors, L.P.
513.85K
-3.27%
Green (Trent S.)
500.00K
--
Geode Capital Management, L.L.C.
404.40K
+0.02%
1
2

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Professional & Commercial Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of National Research Corp is 5.22, ranking 89 out of 156 in the Professional & Commercial Services industry. The company's beta value is 0.52. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. National Research Corp’s latest ESG disclosure is at an average level in the Professional & Commercial Services industry, showing no material impact on overall risk.

Score

Industry at a Glance

Previous score
5.22
Change
0
Beta vs S&P 500 index
0.52
VaR
+3.94%
240-Day Maximum Drawdown
+36.17%
240-Day Volatility
+57.29%

Return

Best Daily Return
60 days
+7.67%
120 days
+16.02%
5 years
+16.02%
Worst Daily Return
60 days
-19.54%
120 days
-19.54%
5 years
-19.54%
Sharpe Ratio
60 days
+0.85
120 days
+0.52
5 years
-0.33

Risk Assessment

Maximum Drawdown
240 days
+36.17%
3 years
+78.35%
5 years
+81.00%
Return-to-Drawdown Ratio
240 days
+0.06
3 years
-0.27
5 years
-0.17
Skewness
240 days
-0.57
3 years
-0.76
5 years
-0.75

Volatility

Realised Volatility
240 days
+57.29%
5 years
+41.25%
Standardised True Range
240 days
+4.75%
5 years
+6.72%
Downside Risk-Adjusted Return
120 days
+61.15%
240 days
+61.15%
Maximum Daily Upside Volatility
60 days
+33.19%
Maximum Daily Downside Volatility
60 days
+56.99%

Liquidity

Average Turnover Rate
60 days
+0.44%
120 days
+0.42%
5 years
--
Turnover Deviation
20 days
+27.05%
60 days
+21.28%
120 days
+15.40%

Peer Comparison

Professional & Commercial Services
National Research Corp
National Research Corp
NRC
5.00 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brady Corp
Brady Corp
BRC
8.77 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
McGrath RentCorp
McGrath RentCorp
MGRC
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ennis Inc
Ennis Inc
EBF
8.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
RB Global Inc
RB Global Inc
RBA
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brinks Co
Brinks Co
BCO
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI